Special Report: The latest addition to the partner portfolio all the way from Asia Pacific. A warm welcome to Bridge Biotherapeutics, for which CEO, James Lee,…
We welcome back Roivant Sciences with open arms for the continuation of their partnership with BaseLaunch Phase II. Sascha Bucher, Head of Global Transactions at…
Congratulations to one of BaseLaunch’s portfolio companies, Polyneuron on their latest milestone: First clinical trial application approval. Wishing you great success with the studies later…
There is an opportunity to participate in a research study interview taking place for those with knowledge of the biopharmaceutical industry in Switzerland. The research should…
We are supporting an exciting project that exploits the role and vulnerabilities of circulating tumor cell clusters, major mediators of metastasis. The team is developing…
“Go start a biotech company in a strong biotech ecosystem” is our conclusion from this Nature paper, which tracks down every biotech start-up emerging (between…